With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...

Designing system algorithms remains challenging, where the discontinuous nature of the solution space often forces system engineers to rely on generic heuristics at the expense of performance. We ...

FILE - In this Tuesday, March 23, 2010 file photo, the Google logo displayed at the Google headquarters in Brussels. The European Union's competition watchdog has slapped a record 2.42 billion euro ...

KALAMAZOO, MI -- Family Health Center is encouraging some patients to get tested for hepatitis and HIV after learning dental equipment wasn’t sterilized properly. Patients who may have been treated ...

Located on 890 square-miles in southeast Idaho, Idaho National Laboratory (INL) is our nation’s nuclear energy laboratory. While INL is a world leader in innovative energy solutions, their primary ...

Bill Harris is the CEO & founder of Evergreen Wealth. He's founded/led eight fintech companies, including PayPal, and Personal Capital. Over the past 150 years, the world of individual investing has ...

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes ...

Nissan just treated the world to a new, rugged pickup. But sadly, it’s not for US. Say hello to Yokohama’s latest rendition of its global Navara truck. The automaker revealed the next-gen model down ...

MILAN, Nov 24 (Reuters) - Italian luxury menswear maker Ermenegildo Zegna on Monday outlined a succession plan, as Chief Executive Gildo Zegna moved to the role of executive chairman, while his sons ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease. Integrase strand ...